CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p
Dan Ma(Shanghai Jiao Tong University), Jie Hong(Shanghai Jiao Tong University), GuangYao Ye(Shanghai Jiao Tong University), Yingying Cao(Nanjing Agricultural University), Tingting Yan(Nanjing Drum Tower Hospital), Chaoqin Shen(Sun Yat-sen University), Huimin Chen(Shanghai Jiao Tong University), Zhenhua Wang, Jie He(Third People's Hospital of Hangzhou), Linlin Ren, Fangfang Guo(First Affiliated Hospital Zhejiang University), Haoyan Chen(Shanghai Jiao Tong University), Haoyan Chen(Shanghai Jiao Tong University), Hua Xiong(Qingdao University), Tingting Yan(Shanghai Jiao Tong University), Zhe Cui(Shanghai Jiao Tong University), Huimin Chen(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Xinyu Zhang(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University)
Cited by 66
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
m6A-dependent glycolysis enhances colorectal cancer progression
|Molecular Cancer|2020|465
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434